40% of CVS Caremark's PBM clients have a negative specialty drug trend

About 40 percent of CVS Caremark clients saw negative specialty drug trends during the first three quarters of 2021, according to a report the pharmacy giant released Feb. 24.

Three takeaways from the report:

1. CVS Caremark maintained an overall drug trend for its clients at 2.4 percent during the first three quarters of 2021.
   
   
2. CVS Caremark managed an industry-low specialty drug trend of 5.8 percent.
   
   
3. About 85 percent of CVS Caremark clients saw a specialty drug trend lower than 10 percent.